Why the obesity epidemic requires a multifaceted approach

The latest stories trending on MedCity News.

Editor's Pick

Top Story Report: A "Multifaceted Approach" Is Needed To Tackle the Obesity Epidemic The obesity epidemic is due to factors like inadequate access to care, stigma and a lack of insurance coverage for effective treatments, according to a new report published in the American Journal of Managed Care. Sponsored 5 Health Reasons to Ditch Concrete Jungles for Countryside Presented by MedCity News & Impact Brands In an increasingly urbanized world, the allure of countryside living is growing stronger, especially when it comes to health and well-being. While cities offer numerous opportunities, rural areas provide unique health benefits that are hard to replicate in urban environments. Let's explore five compelling health reasons why trading skyscrapers for rolling hills might be the best decision for your overall wellness. Learn More Early Bird Rate Extended Until This Friday Due to popular demand we're extending our Early Bird rate offer until this Friday.   You now have until Friday, August 16, to Save $100 on INVEST Digital Health. Grab your tickets today and join us for an unforgettable event on September 18 at Pegasus Park in Dallas.   Save $100, Register NOW

Featured News

What's Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently Health systems have spent billions on portals while investments in modernizing the voice channel — the dominant preference of healthcare consumers — have taken a backseat. Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency FDA approval of Ascendis Pharma's Yorvipath is just in time for patients with hypoparathyroidism as Takeda Pharmaceutical will soon stop making the only drug therapy for the rare disorder. But competition could come from others, including an AstraZeneca peptide in late-stage development. This New Venture Firm Thinks Payers Will Be the Ones to Drive Change in the Healthcare Industry Create Health Ventures announced the close of its inaugural $21 million fund, which is focused on technology for payers. This is because payers are "the lynchpin" for the types of change that the fund wants to see, such as better care access and improved population health outcomes, Managing Partner Amit Aysola said. Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease Merck is acquiring a Curon Biopharmaceuticals drug whose encouraging Phase 1 data were presented during the ASCO annual meeting. The pharmaceutical giant sees potential applications of the bispecific antibody in cancer and autoimmune disease. HHS's Information Blocking Disincentives are a Necessary Step Toward Better Patient Care These disincentives may seem harsh, but we must remember the real stakes involved — when medical records are not readily available at the point of care, patients suffer. Closing the Gap Between Lifespan and Health Span with Predictive Analytics By establishing a standard method of gathering data and utilizing programs like STEADI, we can significantly advance our frailty and fall prevention efforts and improve delivery models for other conditions that impact the most vulnerable members of our population.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 7 In this episode, we  stray from usual healthcare news to the realm of politics — Trump shooting, JD Vance's "childless cat lady" comment, gun rights and laws — though we still touch on mental health. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe